Similar articles for PMID: 9025746

Year	Number of Results
1959	1
1976	1
1985	1
1988	1
1989	1
1990	2
1992	2
1993	2
1994	3
1995	7
1996	8
1997	9
1998	4
1999	4
2000	2
2001	3
2002	2
2003	1
2004	4
2005	5
2006	1
2008	3
2009	1
2013	2
2021	0

1

Evaluation of therapy response in children with untreated malignant lymphomas using technetium-99m-sestamibi.

Kapucu LO, Akyüz C, Vural G, Oguz A, Atasever T, Büyükpamukçu M, Unlü M. Kapucu LO, et al. J Nucl Med. 1997 Feb;38(2):243-7. J Nucl Med. 1997. PMID: 9025746 Free article.

2

Quantitative thallium-201 scintigraphy in childhood osteosarcoma: Comparison with technetuim-99m MDP and magnetic resonance imaging in the evaluation of chemotherapeutic response.

Ilhan IE, Vural G, Berberoglu S, Kapucuoglu N, Cila A, Eke S. Ilhan IE, et al. Pediatr Hematol Oncol. 2005 Mar;22(2):153-62. doi: 10.1080/08880010590907294. Pediatr Hematol Oncol. 2005. PMID: 15805001

3

Double-phase Tc-99m MIBI scintigraphy as a therapeutic predictor in patients with non-Hodgkin's lymphoma.

Song HC, Lee JJ, Bom HS, Chung IJ, Kim HJ, Park YK, Kim EE. Song HC, et al. Clin Nucl Med. 2003 Jun;28(6):457-62. Clin Nucl Med. 2003. PMID: 12911092

4

Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.

Taki J, Sumiya H, Tsuchiya H, Tomita K, Nonomura A, Tonami N. Taki J, et al. J Nucl Med. 1997 Apr;38(4):501-6. J Nucl Med. 1997. PMID: 9098190 Free article.

5

Evaluation of chemotherapy response using technetium-99M-sestamibi scintigraphy in untreated adult malignant lymphomas and comparison with other prognosis factors: a preliminary report.

Kao CH, Tsai SC, Wang JJ, Ho YJ, Ho ST, Changlai SP. Kao CH, et al. Int J Cancer. 2001 Jul 20;95(4):228-31. doi: 10.1002/1097-0215(20010720)95:4<228::aid-ijc1039>3.0.co;2-d. Int J Cancer. 2001. PMID: 11400115 Free article.

6

Combined use of 99mTc-sestamibi and 99mTc-V-DMSA in the assessment of chemotherapy effectiveness in patients with multiple myeloma.

Koutsikos J, Athanasoulis T, Anagnostopoulos A, Velidaki A, Passadi M, Dimopoulos MA, Zerva C. Koutsikos J, et al. J Nucl Med. 2005 Jun;46(6):978-82. J Nucl Med. 2005. PMID: 15937309 Free article.

7

Comparative feasibility of separate or simultaneous rest thallium-201/stress technetium-99m-sestamibi dual-isotope myocardial perfusion SPECT.

Kiat H, Germano G, Friedman J, Van Train K, Silagan G, Wang FP, Maddahi J, Berman D. Kiat H, et al. J Nucl Med. 1994 Apr;35(4):542-8. J Nucl Med. 1994. PMID: 8151372 Free article.

8

Comparative study of technetium-99m-sestamibi and thallium-201 SPECT in predicting chemotherapeutic response in small cell lung cancer.

Yamamoto Y, Nishiyama Y, Satoh K, Takashima H, Ohkawa M, Fujita J, Kishi T, Matsuno S, Tanabe M. Yamamoto Y, et al. J Nucl Med. 1998 Sep;39(9):1626-9. J Nucl Med. 1998. PMID: 9744357 Free article.

9

Scintigraphic evaluation of pancreatic transplants using technetium-99m-sestamibi.

Elgazzar AH, Munda R, Fernandez-Ulloa M, Clark J, Ryan JR, Hughes JA. Elgazzar AH, et al. J Nucl Med. 1995 May;36(5):771-7. J Nucl Med. 1995. PMID: 7738646 Free article.

10

Monitoring response to therapy with thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma.

Kostakoglu L, Uysal U, Ozyar E, Hayran M, Uzal D, Demirkazïk FB, Kars A, Atahan L, Bekdik CF. Kostakoglu L, et al. J Nucl Med. 1997 Jul;38(7):1009-14. J Nucl Med. 1997. PMID: 9225780 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed